Long‐Term Chronic Lung Allograft Dysfunction‐Free Survival Following Lung Transplant in the Presence of Donor‐Specific Antibodies

Documenti analoghi

• The Impact of Donor‐Recipient Human Leukocyte Antigen Matching on Bronchiolitis Obliterans‐Free Survival Among Lung Transplant Recipients With Connective Tissue Diseases
  di: Andrew M. Courtwright, et al.
  Pubblicazione: (2024)
• Aspergillus After Lung Transplantation: Prophylaxis, Risk Factors, and the Impact on Chronic Lung Allograft Dysfunction
  di: Johanna P. van Gemert, et al.
  Pubblicazione: (2025)
• Automated CT Image Processing for the Diagnosis, Prediction, and Differentiation of Phenotypes in Chronic Lung Allograft Dysfunction After Lung Transplantation
  di: Stefan Kuhnert, et al.
  Pubblicazione: (2025)
• Anti‐Thymocyte Globulin as a Therapy for Chronic Lung Allograft Dysfunction: A Single‐Center Experience
  di: Colin T. Dunn, et al.
  Pubblicazione: (2024)
• Lessons From the Utilization of Hepatitis B Virus Nucleic Acid Test Positive Donors for Hepatitis B Vaccinated Lung Transplant Candidates (INHIBITOR) Study
  di: Andrew M. Courtwright, et al.
  Pubblicazione: (2025)